Monday, April 12, 2004

Objectivity of SSRI Pediatric Research Findings Questioned
Reuters Health story at Medscape - "Biased reporting on the benefits of selective serotonin reuptake inhibitors (SSRIs) for children with depression has exaggerated the drugs' benefits and downplayed their adverse effects, according to a review published in the April 10th issue of the British Medical Journal. The US Food and Drug Administration, the UK Committee on Safety of Medicines, and some drug companies have recently issued warnings about using SSRIs in children. However, other researchers support their continued use." [Viewing Medscape resources requires registration, which is free]. See also the article in the British Medical Journal on which the story is based, Efficacy and safety of antidepressants for children and adolescents.